Press release
Consumer-Facing Telemedicine To Drive The Intravitreal (IVT) Injectable Market, Reaching US$ 23,814.3 Mn
According to the most recent Persistence Market Research (PMR) report, the Intravitreal (IVT) Injectables Market will grow at a CAGR of 4.9% between 2022 and 2028, surpassing US$ 23,814.3 million in terms of market value.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/25906
Growing retinal diseases are expected to boost the global intravitreal injectable market at a substantial rate over the forecast period. Millions of people are affected by retinal disorders, which commonly result in vision loss or complete blindness. Intravitreal injection is a safe and easy method of treating retinal disorders.
Company Profiles:
F. Hoffmann-La Roche Ltd
Regeneron Pharmaceuticals, Inc.
Bausch & Lomb
Novartis AG
Allergan
Alimera Sciences
ThromboGenics, Inc.
Bristol-Myers Squibb Company
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/25906
According to the National Eye Institute (NEI), around 2.0 million people in the United States were afflicted by AMD in 2010, with the figure anticipated to more than increase to 5.4 million by 2050. To address rising demand, industry players are focused on innovation by developing a solid pipeline of IVT injections for the treatment of retinal diseases.
Between 2022 and 2028, North America is expected to account for a significant share of the global market. Increased incidence of age-related macular degeneration (AMD) is expected to stimulate demand for intravitreal (IVT) injectables in the United States.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/25906
Due to an increase in the elderly population and an increase in the incidence of retinal illnesses, the European market is also expected to fuel market growth. In the coming years, countries such as India and China are likely to boost demand for intravitreal (IVT) injectables in the Asia Pacific region, due to the presence of a sizable patient pool suffering from diabetes mellitus.
Complete Report Details@ https://www.persistencemarketresearch.com/market-research/intravitreal-ivt-injectable-market.asp
Want More Insights?
PMR has presented a comprehensive report based on Intravitreal (IVT) Injectable Market as per Indication (Diabetic Retinopathy, Macular Degeneration, Endophthalmitis, Retinal Vein Occlusions and Others), Drug Class (Anti-VEGF, Corticosteroids, Antibiotics, Antivirals and Antifungals), Distributional Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies and Others), based on seven regions.
Related Reports:
Cmo Cdmo Biotechnology Market - https://www.persistencemarketresearch.com/market-research/cmo-cdmo-biotechnology-market.asp
Xerostomia (Dry Mouth) Treatment Market - https://www.persistencemarketresearch.com/market-research/xerostomia-treatment-market.asp
Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com
About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Consumer-Facing Telemedicine To Drive The Intravitreal (IVT) Injectable Market, Reaching US$ 23,814.3 Mn here
News-ID: 2658822 • Views: …
More Releases from Persistence Market Research
Automotive Parts Aftermarket Outlook 2023-2033: Key Players Like Bosch, Denso, M …
The Automotive Parts Aftermarket has become a critical component of the global automotive ecosystem. According to Persistence Market Research, the market size reached US$ 548.5 billion in 2022 and is projected to expand to US$ 576.5 billion in 2023. With the replacement parts segment expected to achieve a total value of US$ 984.7 billion by 2033, the market is set to grow at a CAGR of 5.5% from 2023 to…
Centrifugal Pumps Market Set to Reach US$ 55.7 Billion by 2032, Insights from Pe …
The global centrifugal pumps market is poised for significant expansion, with the market projected to grow from US$ 41.2 billion in 2025 to reach US$ 55.7 billion by 2032, reflecting a CAGR of 4.4%. The growth is primarily fueled by increasing demand for efficient water management solutions across agriculture, industrial manufacturing, and municipal services. Centrifugal pumps play a crucial role in ensuring seamless fluid transfer, reducing energy consumption, and maintaining…
CAR T-cell Therapy Market to Touch US$24 Billion by 2032, Reports Persistence Ma …
The global CAR T-cell therapy market is experiencing transformative growth, projected to expand from an estimated US$5.8 billion in 2025 to US$24 billion by 2032, reflecting a compound annual growth rate (CAGR) of 25% during the forecast period from 2025 to 2032. This growth trajectory is being driven by a confluence of factors, including rising cancer prevalence, especially hematologic malignancies, and continuous advancements in gene-editing technologies and immunotherapy. As these…
Hydraulic Fluid Connector Market Technological Innovations, Efficiency Drivers, …
Hydraulic fluid connectors are used only in fluid power and piping systems for efficient operation in industrial fluid networks. A hydraulic fluid connector is deployed in these systems to increase the total machine performance irrespective of applications. Hydraulic fluid connectors are used to enhance uptime in the remote applications such as oil and gas drilling, pipeline installation and mining.
Innovations in the offering of tearout-proof technology for hydraulic…
More Releases for IVT
Intravitreal (IVT) Injectable Market Dynamics: Driving Forces Behind Market Expa …
The healthcare sector, especially in the field of ophthalmology, is witnessing significant growth due to the rising prevalence of eye diseases and advancements in injectable drug delivery systems. One of the most important developments in the treatment of retinal diseases has been the introduction of intravitreal (IVT) injectables. These injectable therapies are used to treat a range of eye conditions, such as age-related macular degeneration (AMD), diabetic retinopathy (DR), diabetic…
Intravitreal (IVT) Injectable Market Transformative Innovations and Future Growt …
𝑰𝒏𝒕𝒓𝒐𝒅𝒖𝒄𝒕𝒊𝒐𝒏
The Intravitreal (IVT) injectable market has emerged as a pivotal segment in ocular therapeutics, driven by the increasing prevalence of retinal disorders and advancements in drug delivery technologies. Intravitreal injections, administered directly into the vitreous humor, have revolutionized the treatment of various ocular conditions such as age-related macular degeneration (AMD), diabetic macular edema (DME), and retinal vein occlusion (RVO). This article explores the transformative innovations shaping the IVT injectable market…
Intravitreal (IVT) Injectable Market Size, Share, Industry, Forecast (2024-2031)
Market Overview:
The global intravitreal injectable market is growing at a CAGR of 5.8% during the forecast period of 2024-2031. Key drivers of market growth include the increasing prevalence of chronic retinal diseases, particularly cataracts, and advancements in drug development by key manufacturers to meet patient needs. However, market growth may be hindered by the risks associated with intravitreal injections.
Market Dynamics:
Growing Prevalence of Cataracts: Cataracts, which are the primary cause of…
The Intravitreal (IVT) Injectable Market To Prove Its Servility To Technological …
According to the most recent Persistence Market Research (PMR) report, the Intravitreal (IVT) Injectables Market will grow at a CAGR of 4.9% between 2022 and 2028, surpassing US$ 23,814.3 million in terms of market value.
Growing retinal diseases are expected to boost the global intravitreal injectable market at a substantial rate over the forecast period. Millions of people are affected by retinal disorders, which commonly result in vision loss or complete…
The Intravitreal IVT Injectable Market to Witness Invigorating Trends
The Intravitreal IVT Injectable Market is expected to grow on an irreversible note in the next 10 years. The future scenario would be data-driven healthcare. This would, in turn, widen the potential for enhancing treatment options. With interoperability taking the centre stage, program participants could access app blueprints, data templates, and security tools. Thus, the big data cloud would turn out to be kinetic. This would result in an upswing…
The Intravitreal IVT Injectable Market to grow on an invincible note
The Intravitreal IVT Injectable Market is expected to grow by leaps and bounds in the forecast period. Nanotechnology’s medical application is on the anvil. As such, nanomedicine is an outcome of the technology operating at the molecular, atomic, or supramolecular scale. The broad application areas of nanomedicine include sensing, imaging, diagnosis, and delivery via medical devices. This would certainly keep the healthcare vertical upgraded continuously.
Hereditary retinal diseases is the major…
